MedPath

Analysis of Initial Adherence and Its Impact on Long-term Adherence to Hormonal Therapy for Breast Cancer

Not Applicable
Conditions
Breast Cancer
Interventions
Behavioral: low adherence intervention group
Registration Number
NCT03186599
Lead Sponsor
Gachon University
Brief Summary

A trial will be conducted on 200 breast cancer patients with adjuvant hormonal therapy. The study included 6 months baseline measurement, and 12 months intervention. Patients will be assigned to high adherence or low adherence group. Then, through randomization, low adherence patients will be assigned to the intervention or control group. Study Coordinator delivers the intervention using the WALKON mobile application. Control participants receive usual care with continuous monitoring using Medication Event Monitoring System (MEMS) device.

Detailed Description

* Baseline measurement (n=200): screening and enrollment

* 3-month visit: collecting MEMS data

* 6-month visit: collecting MEMS data and assigned to the high adherence (n=70) or low adherence group (n=75). The low adherence intervention group (n=75) will be educated about the WALKON mobile application.

* 12-month visit: Control group: collecting MEMS data intervention group: monthly calls + collecting MEMS data

* 18-month visit: collecting MEMS data and interview

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
200
Inclusion Criteria
  • Stage 0-III breast cancer
  • Treated with Adjuvant hormonal therapy
Exclusion Criteria
  • Stage IV breast cancer
  • Breast cancer recurrence or metastasis
  • Severe medical illness

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
low adherence intervention grouplow adherence intervention group* Patient with the WALKON mobile application. * Patient with monthly feedback call * Patients on continuous MEMS monitoring.
Primary Outcome Measures
NameTimeMethod
physical activity (daily steps)12 months

Comparison of daily steps using WALKON application

Secondary Outcome Measures
NameTimeMethod
Medication adherence using MEMS device18 months

Comparison of adjuvant hormonal therapy adherence using MEMS device

Trial Locations

Locations (1)

Asan Medical center

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath